Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

NCT00526656 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: sunitinib malate

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]